<DOC>
	<DOCNO>NCT01159145</DOCNO>
	<brief_summary>The purpose study ass pharmacodynamics ( intragastric pH ) repeat oral administration D961H 10 mg omeprazole 10 mg Japanese healthy male subject classify genotype CYP2C19 assessment percentage time intragastric pH &gt; 4 24 hour dose day 5 .</brief_summary>
	<brief_title>Study Assess Pharmacodynamics/Pharmacokinetics After Repeated Dosing D961H 10 mg Omeprazole 10 mg Japanese Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Healthy Japanese male subject 20 45 year age Genotype CYP2C19 know volunteer panel data H. pylori negative know urea breath test volunteer panel data . Significant clinical illness 2 week precede preentry visit randomisation , judge investigator ( ) , eg , acute inflammatory disease require medical intervention Past present cardiac , renal , hepatic , neurological gastrointestinal disease , judge investigator ( ) , eg , sequelae myocardial infarction , nephritis , hepatitis cerebral infarction Past present severe allergic disease , hypersensitivity food drug ( except seasonal hay fever ) , allergic symptom require medical intervention ( eg , anesthetic use intragastric pH measurement )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>Japanese male</keyword>
	<keyword>homo-EM/hetero-EM/PM</keyword>
</DOC>